{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T23:30:16Z","timestamp":1649028616340},"reference-count":6,"publisher":"AMPCo","issue":"11","license":[{"start":{"date-parts":[[2013,12,16]],"date-time":"2013-12-16T00:00:00Z","timestamp":1387152000000},"content-version":"vor","delay-in-days":15,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Journal of Australia"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.5694\/mja13.10482","type":"journal-article","created":{"date-parts":[[2013,12,16]],"date-time":"2013-12-16T01:00:46Z","timestamp":1387155646000},"page":"746-747","source":"Crossref","is-referenced-by-count":0,"title":["Systematic postmarketing surveillance needed for misused psychoactive pharmaceutical drugs"],"prefix":"10.5694","volume":"199","author":[{"given":"Steven","family":"Moylan","sequence":"first","affiliation":[{"name":"School of Medicine, Deakin University, Geelong, VIC."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3677","published-online":{"date-parts":[[2013,12,16]]},"reference":[{"key":"e_1_2_3_2_2","doi-asserted-by":"publisher","DOI":"10.5694\/mja12.10986"},{"key":"e_1_2_3_3_2","doi-asserted-by":"publisher","DOI":"10.1177\/0004867411432074"},{"key":"e_1_2_3_4_2","volume-title":"Generalised anxiety disorder and panic disorder (with or without agoraphobia) in adults. NICE clinical guideline 113","author":"National Institute for Health and Clinical Excellence","year":"2011"},{"key":"e_1_2_3_5_2","doi-asserted-by":"publisher","DOI":"10.1177\/0004867412453774"},{"key":"e_1_2_3_6_2","first-page":"11","article-title":"Warning: alprazolam (Xanax, Kalma, Zamhexsal)","author":"Medical Practitioners Board of Victoria","year":"2009","journal-title":"Bulletin"},{"key":"e_1_2_3_7_2","volume-title":"Newsletter number 42. Information circular for pharmacists in Tasmania. New restrictions on the prescribing of alprazolam","author":"Galloway J","year":"2007"}],"container-title":["Medical Journal of Australia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.5694\/mja13.10482","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.5694\/mja13.10482","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.5694\/mja13.10482","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,27]],"date-time":"2020-09-27T00:49:36Z","timestamp":1601167776000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.5694\/mja13.10482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":6,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["10.5694\/mja13.10482"],"URL":"https:\/\/doi.org\/10.5694\/mja13.10482","archive":["Portico"],"relation":{},"ISSN":["0025-729X","1326-5377"],"issn-type":[{"value":"0025-729X","type":"print"},{"value":"1326-5377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12]]}}}